Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Subha Madhavan, Clifford Baron

Premium

Personalized Cancer Therapy (Perthera), a company that develops precision cancer drugs, has hired Subha Madhavan, as its chief data officer. Madhavan will head up the planning and organization of Perthera's data analytic framework, standards, and quality control.

Madhavan is director of the Innovation Center for Biomedical Informatics at the Georgetown University Medical Center and leads the biomedical informatics program at the Georgetown-Howard CTSA. She was also principal investigator of the Breast and Colon Cancer Family Registries data center, which collects public health and epidemiology data from twelve sites in the US, Australia, and Canada. She recently partnered with the US Food and Drug Administration on its Center for Excellence in Regulatory Science program, which aims to advance evidence criteria in the areas of pharmacogenomics and vaccine safety.


CollabRx has appointed Clifford Baron as its VP and chief operating officer. Previously Baron was at Accelrys, directing various functions, including biology product marketing, business development, and professional services. He also founded Lexigraphic, a firm consulting biotechnology startups, and was senior director of global solutions at Applied Biosystems.

Filed under

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.